Cytek Biosciences, Inc. (CTKB) stock
CTKBNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 8/308% below fair value
$5.84+0.32 (+5.80%)
Close on Nov 13, 2026Market cap $759.10MP/E –Yield –
Cytek Biosciences enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Cytek Biosciences's enterprise value was $674.85M on Nov 11, 2026, against $629.16M a year earlier. Over the last 5 years it ranged from $258.15M to $1.81B, with a median of $685.07M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $674.85M | +22.2% |
| 2025 | Dec 31, 2025 | $552.44M | -18.7% |
| 2024 | Dec 31, 2024 | $679.88M | -36.6% |
| 2023 | Dec 29, 2023 | $1.07B | +3.6% |
| 2022 | Dec 30, 2022 | $1.04B | -42.7% |
| 2021 | Dec 31, 2021 | $1.81B | – |
See a number that looks wrong?